HFpEF Is Arguably the Greatest Unmet Need in Cardiology: The Potential Role of SGLT2 Inhibitors

Join Dr Butler as he discusses actual and future therapies of HFpEF. Credit available for this activity expires: 5/5/2022 Earn Credit / Learning Objectives & Disclosures: https://www.medscape.org/viewarticle/950368?src=mkm_podcast_addon_950368